Demographic and clinical characteristics of patients with interstitial lung disease admitted to Razi Hospital, the North of Iran

Heydar Ali Balou, Somaye Ramezanpour, Banafsheh Ghavidel-Parsa, Alireza Jafarinejad, Ali Alavi Foumani


Respiratory disease is the third cause of death, which accounts for one-seventh of all deaths worldwide and millions of people suffer from chronic lung disease in the world. Interstitial lung diseases (ILDs) are one of the most important lung diseases. So, we aimed to evaluate demographic data and clinical characteristics of ILD patients in our region. This cross-sectional descriptive study was conducted on patients diagnosed with ILD who were referred to Razi Hospital, Rasht, Iran during 2013-2018. Out of a total of 300 participants, 160 (53.3%) patients were non-occupational exposed. The most prevalent clinical symptoms and signs were coughs, dyspnea, and abnormal findings in lung auscultation. Totally, 113 (37.7%) of patients mostly consumed methotrexate. Among 158 patients with reported antinuclear antibody (ANA) status, 29 (18.4%) cases were positive. In 186 (71.3%) cases with available pathological findings, alveolar wall thickening, fibroblast deposition, and honeycomb pattern was reported. Also, granulomatous lung tissue and diffuse fibrosis were detected in 58 (22.2%) patients.  ILD patients with different clinical conditions may show regional differences in risk factors, patient exposure, access to medical facilities for diagnosis and treatment, and genetic differences, which require careful attention to these factors individually in each region. 


Demographic data; Clinical characteristics; Radiological findings; Interstitial lung disease

Full Text:

Full-text PDF


Tolouee A, Abrishami Moghaddam H, Gity M. Automatic Classification of Lung Tissue Patterns in HRCT Images of Patients Affected with ILD. Signal Data Process. 2010; 6(2):27-38.

Attili AK, Kazerooni EA, Gross BH, Flaherty KR, Myers JL, Martinez FJ. Smoking-related interstitial lung disease: radiologic-clinical-pathologic correlation. Radiographics. 2008;28(5):1383–96.

Joyseeree R, Müller H, Depeursinge A. Rotation-covariant tissue analysis for interstitial lung diseases using learned steerable filters: Performance evaluation and relevance for diagnostic aid. Comput Med imaging Graph. 2018;64:1–11.

Dhooria S, Agarwal R, Sehgal IS, Prasad KT, Garg M, Bal A, et al. Spectrum of interstitial lung diseases at a tertiary center in a developing country: A study of 803 subjects. PLoS One. 2018;13(2):e0191938.

Rivera-Ortega P, Molina-Molina M. Interstitial lung diseases in developing countries. Ann Glob Heal. 2019;85(1):1-14.

Alhamad EH. Interstitial lung diseases in Saudi Arabia: A single-center study. Ann Thorac Med. 2013; 8(1):33-7.

Hassan RI, Lubertino LI, Barth MA, Quaglia MF, Montoya SF, Kerzberg E, et al. Lung ultrasound as a screening method for interstitial lung disease in patients with systemic sclerosis. J Clin Rheumatol. 2019;25(7):304–7.

Musellim B, Okumus G, Uzaslan E, Akgün M, Cetinkaya E, Turan O, et al. Epidemiology and distribution of interstitial lung diseases in T urkey. Clin Respir J. 2014;8(1):55–62.

Travis WD, Costabel U, Hansell DM, King Jr TE, Lynch DA, Nicholson AG, et al. An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2013;188(6):733–48.

Saghafi M, Sahebari M, Nabavi S, Salari M, Mirfeizi SZ, Rezaeiyazdi Z, et al. Clinical and epidemiological manifestation of 100 patients with sarcoidosis and sarcoid arthritis. Med J mashhad Univ Med Sci. 2015;58(5):270–5.

Vij R, Noth I, Strek ME. Autoimmune-featured interstitial lung disease: a distinct entity. Chest. 2011;140(5):1292–9.

Foumani AA, Akhoundzadeh N, Karkan MF. Sarcoidosis, a report from Guilan (an Iranian Northen province)(2001-09). Sarcoidosis Vasc Diffus Lung Dis. 2014;31:282–8.

Raghu G, Chen S-Y, Hou Q, Yeh W-S, Collard HR. Incidence and prevalence of idiopathic pulmonary fibrosis in US adults 18–64 years old. Eur Respir J. 2016;48(1):179–86.

Choi W-I, Dauti S, Kim HJ, Park SH, Park JS, Lee CW. Risk factors for interstitial lung disease: a 9-year Nationwide population-based study. BMC Pulm Med 2018;18(1):96.

Schneider J, Brückel B, Fink L, Woitowitz H-J. Pulmonary fibrosis following household exposure to asbestos dust? J Occup Med Toxicol. 2014;9(1):39.

Gysbrechts C, Michiels E, Verbeken E, Verschakelen J, Dinsdale D, Nemery B, et al. Interstitial lung disease more than 40 years after a 5 year occupational exposure to talc. Eur Respir J. 1998;11(6):1412–5.

Kim MY, Kim D, Shin J-A, Ahn HK, Choi B-S. Interstitial lung disease in seven construction worker who built an extension on hydrofluoric gas manufacturing factory. Eur Respiratory Soc; 2018;52(suppl 62):PA1204.

Carvajalino S, Reigada C, Johnson MJ, Dzingina M, Bajwah S. Symptom prevalence of patients with fibrotic interstitial lung disease: a systematic literature review. BMC Pulm Med. 2018;18(1):78.

Siribaddana A, Pathirathne H, Palitha R, Rodrigo G. Demographics and patterns of lung involvement and survival in patients with rheumatoid arthritis and interstitial lung disease in a tertiary care setting of Sri Lanka. Chest. 2019;155(4):132A.

Sheikh V, Basiri Z, Esna Ashari F, Jabari M, Pishva Y. High-resolution computed tomography and chest X-ray findings of interstitial lung disease related to systemic sclerosis. Avicenna J Clin Med. 2012;19(2):16–22.

Hu Y, Wang L-S, Wei Y-R, Du S-S, Du Y-K, He X, et al. Clinical characteristics of connective tissue disease-associated interstitial lung disease in 1,044 Chinese patients. Chest. 2016;149(1):201–8.

Sarwar Zubairi A Bin, Hassan M, Shahzad T, Sarwar S, Abbas A, Ahmad H, et al. Spectrum of interstitial lung disease from a tertiary care hospital in Karachi. J Pak Med Assoc. 2017;67(7):1065-9.

Duchemann B, Annesi-Maesano I, de Naurois CJ, Sanyal S, Brillet P-Y, Brauner M, et al. Prevalence and incidence of interstitial lung diseases in a multi-ethnic county of Greater Paris. Eur Respir J. 2017;50(2):1602419.

Hyldgaard C, Hilberg O, Muller A, Bendstrup E. A cohort study of interstitial lung diseases in central Denmark. Respir Med. 2014;108(5):793–9.

Vivero F, Campins F, Lancellotti D, Malfante P, Babini S, Sebastiani J, et al. Autoimmune interstitial lung disease in Latin-America. Clin Immunol. 2019;199:52–6.

Singh S, Collins BF, Sharma BB, Joshi JM, Talwar D, Katiyar S, et al. Interstitial lung disease in India. Results of a prospective registry. Am J Respir Crit Care Med. 2017;195(6):801–13.

Vaseer S, James JA, Thanou A, Merrill JT. Characteristics of lupus patients with interstitial lung disease and relationship with Jo-1 antibody. In: Arthritis & Rheumatology. Wiley-Blackwell 111 River St, Hoboken 07030-5774, NJ USA; 2014. bl S308–9.

Omote N, Taniguchi H, Kondoh Y, Watanabe N, Sakamoto K, Kimura T, et al. Lung-dominant connective tissue disease: clinical, radiologic, and histologic features. Chest. 2015;148(6):1438–46.



  • There are currently no refbacks.

Copyright (c) 2022 © The Author(s)

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.